Sumitomo Chemical Company (4005) Stock Overview
Engages in Agro & Life Solutions, ICT & Mobility Solutions, Advanced Medical Solutions, Essential & Green Materials, and Sumitomo Pharma. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
4005 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Sumitomo Chemical Company, Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥458.20 |
| 52 Week High | JP¥495.90 |
| 52 Week Low | JP¥282.60 |
| Beta | 0.37 |
| 1 Month Change | -6.01% |
| 3 Month Change | 25.53% |
| 1 Year Change | 10.20% |
| 3 Year Change | -10.16% |
| 5 Year Change | 26.23% |
| Change since IPO | -4.94% |
Recent News & Updates
Recent updates
Getting In Cheap On Sumitomo Chemical Company, Limited (TSE:4005) Is Unlikely
Oct 12
Is Sumitomo Chemical Company, Limited (TSE:4005) Trading At A 48% Discount?
Jul 24Sumitomo Chemical Company's (TSE:4005) Promising Earnings May Rest On Soft Foundations
Jun 27What Sumitomo Chemical Company, Limited's (TSE:4005) P/S Is Not Telling You
Jun 12Is There An Opportunity With Sumitomo Chemical Company, Limited's (TSE:4005) 50% Undervaluation?
Apr 18Is Sumitomo Chemical Company (TSE:4005) Using Too Much Debt?
Mar 19The Price Is Right For Sumitomo Chemical Company, Limited (TSE:4005)
Feb 26
V-Shaped Recovery Driven By Critical Shifts Into IT-Related Chemicals And Pharmaceuticals Boosts Profits
Business portfolio upgrade and structural reforms aim to boost revenue and net margins in high-performing segments while reducing reliance on loss-making operations.Are Investors Undervaluing Sumitomo Chemical Company, Limited (TSE:4005) By 44%?
Nov 24Sumitomo Chemical Company, Limited (TSE:4005) Just Reported Half-Year Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 02Sumitomo Chemical Company, Limited's (TSE:4005) P/S Still Appears To Be Reasonable
Oct 29Shareholder Returns
| 4005 | JP Chemicals | JP Market | |
|---|---|---|---|
| 7D | -4.0% | -4.1% | -2.8% |
| 1Y | 10.2% | -0.1% | 14.3% |
Return vs Industry: 4005 exceeded the JP Chemicals industry which returned -0.1% over the past year.
Return vs Market: 4005 underperformed the JP Market which returned 14.3% over the past year.
Price Volatility
| 4005 volatility | |
|---|---|
| 4005 Average Weekly Movement | 3.8% |
| Chemicals Industry Average Movement | 3.2% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in JP Market | 7.7% |
| 10% least volatile stocks in JP Market | 1.9% |
Stable Share Price: 4005 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 4005's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1913 | 29,279 | Nobuaki Mito | www.sumitomo-chem.co.jp |
Sumitomo Chemical Company, Limited engages in Agro & Life Solutions, ICT & Mobility Solutions, Advanced Medical Solutions, Essential & Green Materials, and Sumitomo Pharma. The Agro & Life Solutions segment offers crop protection chemicals, fertilizers, agricultural materials, household insecticides, products for control of infectious diseases, and feed additives, etc. The ICT & Mobility Solutions segment provides optical products, semiconductor processing materials, compound semiconductor materials, touch screen sensor panels, high-purity aluminum and alumina, specialty chemicals, additives, engineering plastics, and battery materials, etc. The Advanced Medical Solutions segment offers contract development and manufacturing organization business for small-molecule active ingredients and intermediates, oligonucleic acid drug substances, and regenerative medicine, and cell therapy products, etc. The Essential & Green Materials segment offers synthetic resins, raw materials for synthetic fibers, various industrial chemicals, methyl methacrylate products, synthetic resin processed products, industrial aluminum and alumina, and synthetic rubber, etc. The Sumitomo Pharma segment offers small molecule pharmaceuticals. Sumitomo Chemical Company, Limited was founded in 1913 and is headquartered in Tokyo, Japan.
Sumitomo Chemical Company, Limited Fundamentals Summary
| 4005 fundamental statistics | |
|---|---|
| Market cap | JP¥749.94b |
| Earnings (TTM) | JP¥9.69b |
| Revenue (TTM) | JP¥2.52t |
Is 4005 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4005 income statement (TTM) | |
|---|---|
| Revenue | JP¥2.52t |
| Cost of Revenue | JP¥1.80t |
| Gross Profit | JP¥717.34b |
| Other Expenses | JP¥707.66b |
| Earnings | JP¥9.69b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Nov 04, 2025
| Earnings per share (EPS) | 5.92 |
| Gross Margin | 28.46% |
| Net Profit Margin | 0.38% |
| Debt/Equity Ratio | 117.6% |
How did 4005 perform over the long term?
See historical performance and comparisonDividends
Does 4005 pay a reliable dividends?
See 4005 dividend history and benchmarks| Sumitomo Chemical Company dividend dates | |
|---|---|
| Ex Dividend Date | Sep 29 2025 |
| Dividend Pay Date | Dec 03 2025 |
| Days until Ex dividend | 17 days |
| Days until Dividend pay date | 48 days |
Does 4005 pay a reliable dividends?
See 4005 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/15 00:47 |
| End of Day Share Price | 2025/10/15 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Sumitomo Chemical Company, Limited is covered by 20 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Mikiya Yamada | Barclays |
| Takashi Enomoto | BofA Global Research |
| Atsushi Ikeda | Citigroup Inc |